Showing results (81-90 of 104) with videos related to
Sort By:
Pageof 11
The American Journal of Surgical Pathology|January 31, 2015
Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinomaKate O'Connor, Hector H Li-Chang, Steven E Kalloger, et al.Histopathology|April 17, 2024
Tumour budding as a prognostic biomarker in biopsies and resections of neoadjuvant-treated rectal adenocarcinomaSusan Aherne, Mark Donnelly, Éanna J Ryan, et al.Human Pathology|July 19, 2017
The impact of knowledge transfer on the detection of venous invasion in colorectal cancerRichard Kirsch, Naziheh Assarzadegan, David E Messenger, et al.Annals of Surgery|July 9, 2021
Dataset for Pathology Reporting of Colorectal Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR)Maurice B Loughrey, Fleur Webster, Mark J Arends, et al.The American Journal of Surgical Pathology|October 31, 2012
Venous invasion in colorectal cancer: impact of an elastin stain on detection and interobserver agreement among gastrointestinal and nongastrointestinal pathologistsRichard Kirsch, David E Messenger, Robert H Riddell, et al.United European Gastroenterology Journal|January 9, 2024
Lymph node metastases and recurrence in pT1 colorectal cancer: Prediction with the International Budding Consortium Score-A retrospective, multi-centric studyHeather Dawson, John-Melle Bokhorst, Linda Studer, et al.Annals of Surgical Oncology|June 17, 2026
Two-Year Outcomes after Direct-to-Surgery in Good Prognosis Margin-Clear Stage II or III Rectal Cancer: The QuickSilver StudyErin D Kennedy, Marko Simunovic, Selina Schmocker, et al.Histopathology|January 29, 2021
Histopathological diagnosis of tumour deposits in colorectal cancer: a Delphi consensus studyAmy Lord, Gina Brown, Muti Abulafi, et al.Journal for Immunotherapy of Cancer|March 17, 2022
Recommendations for standardizing biopsy acquisition and histological assessment of immune checkpoint inhibitor-associated colitisChristopher Ma, Rish K Pai, David F Schaeffer, et al.British Journal of Cancer|June 4, 2024
Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancerYuichiro Tsukada, Hideaki Bando, Koji Inamori, et al.Pageof 11